Regen BioPharma, Inc. Files Provisional Patent on CAR-T Cell Capable of Attracting and Educating Naïve T Cells to Kill Cancer
![](https://www.regenbiopharmainc.com/wp-content/uploads/2017/10/Peachpuff-Brush-Stroke-Photography-Logo.png)
Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today filing of a provisional patent application with the USPTO entitled…